Skip to main content
Argonne National Laboratory


Argonne Impacts State by State

Argonne’s collaborations in California and across the United States have led to groundbreaking discoveries and development of new technologies that help meet the nation’s needs for sustainable energy, economic prosperity, and security.

Caltech researchers decode complex cellular machinery

Artist’s rendition of the nuclear pore complex dotting the surface of a cell’s nucleus. (Image by Valerie Altounian/Science.)

The nucleus of every cell in our bodies contains many complicated parts. One of the most intricate is called the nuclear pore complex, or NPC. Shaped like a donut with spider legs, the NPC serves as a gateway and guardian to the inner workings of the nucleus. It expands and contracts to allow beneficial things in, and keep harmful things out. Mutations in the NPC have been linked to many diseases, including Lou Gherig’s disease (known as ALS), and heart conditions, so understanding how it works may lead to better treatments.

A research team led by Caltech has spent nearly 20 years creating a full structural map of the NPC. Using the ultrabright X-rays of the Advanced Photon Source (APS), a U.S. Department of Energy Office of Science user facility at DOE’s Argonne National Laboratory — along with other similar facilities — researchers painstakingly determined the atomic structure of the NPC, protein by protein. This information greatly increases our knowledge and understanding of how the NPC works. The research was published in Science.

USC scientists use Argonne computing power, discover new application for ancient art

A length of 2D kirigami made of molybdenum disulfide, designed by reinforcement learning. (Image by Ken-ichi Nomura and Pankaj Rajak/University of Southern California.)

Scientists at the University of Southern California in Los Angeles used supercomputers and kirigami — the ancient Japanese art of paper cutting — at the Argonne Leadership Computing Facility (ALCF), a U.S. Department of Energy Office of Science user facility located at Argonne, to make inroads in wearable electronics. By combining kirigami (which involves making exacting cuts to create intricate patterns) with autonomous reinforcement learning, the team is advancing the development of strong, stretchable materials for wearable electronics.

Knowing that a series of precise cuts would make a material strong and stretchable, the team created a two-dimensional length of molybdenum disulfide, a material that can be embedded with electronics. To arrive at the right kirigami pattern, the team used Argonne supercomputers to conduct thousands of simulations.

After the model learned kirigami design strategies, researchers used it to produce a combination of about one billion possible stretches and cuts. Using reinforcement learning (an artificial intelligence (AI) technique), the computer taught” itself to produce a structure with optimal stretchability.

The ALCF is a DOE Office of Science user facility. USC’s work at the ALCF was funded by the National Science Foundation’s Future Manufacturing Program; the DOE Office of Science, Advanced Scientific Computing Research program; and the DOE Office of Science: Basic Energy Sciences and Advanced Scientific Computing Research program.

Oakland-based New Energy Nexus joins Argonne-led public-private alliance to build lithium battery supply chain

Lithium is extracted from brine pools like these in the Earth’s crust, bearing a high concentration of lithium carbonate. (Image by Shutterstock/Cavan-Images.)

As widespread electrification drives demand for lithium-based batteries, the battery supply chain in the U.S. must expand. To achieve this goal, battery manufacturers must expand their output by 20 to 30 times and establish a secure and sustainable supply chain. Argonne announced the creation of Li-Bridge, a public-private alliance committed to building this supply chain.

In the first collaboration of its kind in the U.S. battery industry, New Energy Nexus in Oakland joined two other trade associations ― NAATBatt International and New York Battery and Energy Storage Technology Consortium, Albany ― to represent more than 600 industry stakeholders to improve the supply chain. Argonne serves as the facilitator between private industry and the Federal Consortium for Advanced Batteries, which recently released a national blueprint” for lithium batteries to the year 2030. The plan puts the United States on a path to long-term competitiveness in the global battery value chain, outlining five critical goals for generating equitable, clean-energy jobs while mitigating climate change.

Argonne will work with DOE national laboratories across the country to meet national goals. The new alliance is seen as a major step forward in developing and sustaining the battery supply chain — critical to building electric vehicles and maintaining competitiveness worldwide.

Cerebras and Argonne collaboration leads to fastest AI system

Argonne leverages unprecedented performance from Cerebras CS-1 to solve deep learning computational and science problems. (Image by Argonne National Laboratory)

The world’s fastest AI computer, Cerebras CS-1, is the result of a collaboration between Argonne and Cerebras Systems in Los Altos, which focuses on accelerating artificial intelligence compute. Argonne was the first national laboratory to deploy the system in 2019 to solve deep learning computational and science problems. Deep learning, a subset of AI, allows computer networks to learn from large amounts of unstructured data.

The CS-1 integrates the Wafer Scale Engine, the fastest AI processor ever built, and enables AI practitioners to answer more questions and explore more ideas in less time. The CS-1 delivers record-breaking performance and scale to AI compute, and its deployment across national laboratories enables the largest supercomputer sites in the world to achieve a hundredfold to a thousandfold improvement over existing AI accelerators.

Argonne-led energy storage consortium technology leads to Sepion startup

JCESR helps advance promising areas of energy science and engineering from the earliest stages of research to the point of commercialization. (Image by Argonne National Laboratory)

Sepion Technologies in Emeryville was launched using technology developed at the Joint Center for Energy Storage Research (JCESR), one of DOE’s Energy Innovation Hubs. Led by Argonne, JCESR is a partnership of national laboratories, universities and industrial firms with more than 150 researchers. Its mission is to create materials that can be mixed and matched to build a diversity of next-generation batteries to transform transportation and the electric grid the way lithium-ion batteries transformed consumer electronics. JCESR developed a polymer membrane as a component of a novel design for the cells that make up a battery. That membrane gave birth to Sepion.

Since then, Sepion has been commercializing a membrane platform with a suite of products that enhance the performance and economics of lithium batteries and flow batteries. At the heart of the technology are membranes that can be dropped in with existing manufacturing processes to minimize barriers to market entry, the company website said.

Argonne teams with California firms on new drug for melanoma patients

Frequently or severely sunburned skin can cause skin cancer, as seen in this microscope image. Zelboraf®, a drug developed with the help of X-ray light sources, can limit the cancer’s growth. (Image by Convit/Shutterstock)

Researchers from drug discovery company Plexxikon Inc. in Berkeley and biotechnology company Genentech in San Francisco collaborated with Argonne to develop Zelboraf®, which is sold in nearly 50 countries.

While using Argonne’s Advanced Photon Source, a DOE Office of Science user facility, researchers determined the structure of a cancer‑causing mutated protein. They searched through hundreds of molecules to determine the structure of the one that could halt the cancer’s spread. The researchers wanted to develop a drug to prevent the enzyme from multiplying. The molecule the scientists selected to use in the drug functions like a lock-and-key mechanism, binding tightly to the mutated protein and blocking signals from it that tell cancer cells to multiply. The U.S. Food and Drug Administration approved Zelboraf® in 2011.